Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship

Funding Agency:
National Institutes of Health

The participating Institutes and Centers (ICs) are inviting applications to support administrative supplements to existing awards of scientists who are outstanding mentors and who have demonstrated compelling commitments and contributions to enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. Excellent mentorship and superior training are critical to the development of exceptional future scientists. This administrative supplement recognizes the crucial role great mentors play in the development of future leaders in the scientific research enterprise.

The supplement awards will provide up to $250,000.00 (direct costs), not to exceed the cost of the parent award, to grants supporting faculty members who have mentoring and/or mentorship as part of their existing awards and have demonstrated a commitment to outstanding mentorship and training, especially to individuals from groups identified as underrepresented in the biomedical sciences (e.g., see the Notice of NIH's of Interest in Diversity). As administrative supplements, the work proposed needs to be within the scope of the research or training that is already supported. The award must have a component related to mentoring. Examples include but are not limited to: a Research Education Program that describes mentored research experiences, a Career Development section, a Plan to Enhance Diverse Perspectives, or a discrete objective related to mentoring.

Funds will be provided to perform additional research within the scope of the parent grant, to develop curricula or training activities to enhance mentor training, and/or to help foster the research career development of additional students, post-doctorates, or other trainees, and/or for additional trainee slots.

To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment. The award may not be in a terminal no-cost extension or going into a no-cost extension in fiscal year 2022.

If interested in this opportunity, Duke investigators should contact:

Cinthia E. Sanchez, Ph.D. (, CTSA Program Director, Duke Clinical & Translational Science Institute (CTSI) 

Application Due Date – April 7, 2022 





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 7, 2022